340B UNIVERSITY Las Vegas Edition. May 31, 2014
|
|
- Meryl Lindsey
- 8 years ago
- Views:
Transcription
1 340B UNIVERSITY Las Vegas Edition May 31, 2014
2 SESSION 1: THE TOP 5: 340B BASICS FOR HOSPITALS Mike Benedict
3 Objectives 1. Define the intent of the 340B Program 2. Describe the major 340B stakeholders 3. Explain how to participate in 340B 4. Identify how the Prime Vendor Program supports 340B stakeholders 5. List the program rules and explain how to follow them
4 Takeaways 1. The intent of 340B: to support entities that serve vulnerable patients so the entities stay in business 2. Major 340B stakeholders: federal government, certain drug manufacturers, certain covered entities, 340B Prime Vendor Program, managed by Apexus 3. Covered entities must register on the HRSA Database; once a year they must recertify accuracy of HRSA 340B database information
5 Takeaways 4. The 340B Prime Vendor Program provides: Truth (call center) Teamwork (contracting with distributors and suppliers) Teaching (340B University) 5. Covered entities must maintain auditable records: Only patients of the covered entity receive 340B drugs A Medicaid rebate is not paid on a 340B drug All eligibility criteria are met
6 1. 340B PROGRAM INTENT AND OVERVIEW
7 340B Intent To permit covered entities to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. H.R. Rep. No (II), at 12 (1992)
8 Share Which examples below describe 340B program savings used in alignment with 340B program intent? Discuss at your table. A. Supporting an indigent care clinic B. Starting a patient assistance medication program C. Subsidizing medications for patients unable to pay D. Adding pharmacy staff
9 340B Statute Resulted from a 1992 federal statute Manufacturers participating in Medicaid Drug Rebate Program must sign a Pharmaceutical Pricing Agreement (PPA) with the Secretary of Health and Human Services The manufacturer agrees to charge a price for covered outpatient drugs that does not exceed the 340B price
10 340B Price Calculated quarterly 340B ceiling price = Average Manufacturer Price (AMP) Medicaid Unit Rebate Amount (URA) Manufacturer submits data to CMS
11 Relative Pricing 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 100% 79% 66% 64% 58% 53% Private Sector Pricing 51% 49% 42% Adapted from a slide by Safety Net Hospitals for Pharmaceutical Access Source: Data derived from Prices for Brand-Name Drugs Under Selected Federal Programs, Congressional Budget Office (June 2005)
12 340B Covered Outpatient Drugs* Vaccines Inpatient drugs Drug not directly reimbursed FDA doesn t require NDC Outpatient Prescription Drugs Over-the-counter drugs (with a prescription) Clinic administered drugs Biologics Insulin
13 Program Evolution Access Sub-Regulatory Integrity Regulatory
14 Have you been here?
15 340B Program Integrity Manufacturer Calculate and charge a correct 340B price Subject to HRSA audits Entity Comply with 340B statute and guidelines Subject to HRSA and manufacturer audits OPA Program Integrity Page:
16 Concerns from Peers I m afraid I ll have an audit and not be aware of a particular aspect of the program, even though I ve tried to stay on top of everything. I worry about how to apply certain policies; it seems that there are different interpretations of the right thing to do.
17 Share Please share your primary 340B program integrity concern with the person sitting next to you.
18 Review Which of the following is a 340B covered outpatient drug? a) Vaccine b) Inpatient drugs c) Over the counter drug not prescribed in writing by an authorized provider d) None of the above are covered outpatient drugs
19 Entities Take Action 1. Describe how your entity s use of the 340B program supports the intent of the 340B program. 2. Identify how your entity can document the use of 340B savings to align with the intent of the 340B program. 3. Incorporate these elements into your 340B related standard operating procedures. 4. Rely on trusted resources identified by OPA as the source of truth for 340B issues: OPA and Apexus.
20 2. MAJOR 340B STAKEHOLDERS
21 Major 340B Stakeholders Manufacturer Calculate Entity and offer Provide 340B price 340B access OPA Administer 340B program 340B Drug to Patient
22 HRSA Office of Pharmacy Affairs (OPA) Health Resources and Services Administration (HRSA) Oversees 340B program administration (enrollment, recertification, compliance) Establishes mechanism to prevent duplicate discounts OPA support The 340B Prime Vendor Program, managed by Apexus Apexus is not the same thing as HRSA; Apexus communicates HRSA policy
23 HRSA-Endorsed Resources HRSA Apexus
24 340B Eligible Entities* Federal Grantees/Designees Federally Qualified Health Center Federally Qualified Health Center Look-Alikes Title X Family Planning Grantees State Aids Drugs Assistance Programs Ryan White Care Act Grantees (A,B,C,D,F) Black Lung Clinics Hemophilia Treatment Centers Native Hawaiian Health Centers Urban Indian Organizations Sexually Transmitted Disease Grantees Tuberculosis Grantees Certain Hospitals Disproportionate Share Hospitals Children s Hospitals Critical Access Hospitals Free Standing Cancer Hospitals Rural Referral Centers Sole Community Hospitals
25 340B Hospital Eligibility Entity Type Non-profit/ Govt. Contract DSH% GPO Prohibition* Orphan Drug* Applies? Disproportionate Share Hospital (DSH) Yes >11.75% Yes No Children s Hospital (PED) Yes >11.75% Yes No Free-standing Cancer Hospital (CAN) Yes >11.75% Yes Yes
26 340B Hospital Eligibility Entity Type Non-profit/ Govt. Contract DSH% GPO Prohibition* Orphan Drug* Applies? Critical Access Hospital (CAH) Yes N/A No Yes Rural Referral Center (RRC) Yes > 8% No Yes Sole Community Hospital (SCH) Yes > 8% No Yes
27 3. PARTICIPATION IN 340B
28 To Participate in 340B, an Entity must 1. Ensure it has the capability to follow (and maintain auditable records documenting compliance with) program rules 2. Register on the HRSA 340B database 3. Recertify with HRSA annually
29 HRSA 340B Database* The HRSA 340B Database is the official source of 340B information Entities* Contract Pharmacies* Manufacturers Medicaid Exclusion File*
30 340B Database: Statistics 340B database: APR ,196 registered sites: 11,718 are hospital sites 14, 485 unique contract pharmacies >$7.5B/year in 340B drug purchases ~82% of 340B participants enrolled with Apexus
31 340B Database: Statistics, continued APR % of covered entity sites utilize contract pharmacies 89% of covered entity sites use only in-house or inhouse and one contract pharmacy Of sites using contract pharmacy, 73% have five or fewer contract pharmacy arrangements
32 Working with the HRSA 340B Database Entities DO NOT need to log into the 340B database All links referenced on the homepage are accessible without a username & password
33 Working with the HRSA 340B Database When searching for your covered entity s profile - LESS IS MORE The 340B ID is the most reliable search criteria
34 Working with the HRSA 340B Database Covered entity data is divided between tabs on the 340B profile The information about your facility can be found under the applicable tabs
35 HRSA 340B Database: Medicaid
36 Working with the HRSA 340B Database Important Notifications & What s New o Great resource for important notifications about: Registration Recertification Change requests Database changes
37 Registration Process* New entities, entity sites, contract pharmacies, Medicaid information 2 week registration periods, quarterly updates made to OPA Database Update Official October 1 January 1 April 1 July 1 Registration Period July 1 15 October 1-15 January 1 15 April 1-15 Change requests: changes to existing information, rolling basis
38 Apexus Answers What types of documentation must a hospital supply to HRSA to register?
39 Hospital Cost Report A 340B Eligible clinics should be reimbursable ( on lines ) E Part A S2 340B Eligibility if line 33 shows DSH% >11.75 or 8%, depending upon hospital type Hospital ownership /control on line 21 S Date and Time of eligibility-signature block C Shows outpatient charges
40 Worksheet A
41 Worksheet E, Part A
42 Worksheet S2
43 Worksheet S
44 Worksheet C
45 Outpatient Clinics Use 340B only in clinics that: Appear as reimbursable on the most recently filed Medicare Cost Report Are integral parts of the hospital Use 340B for patients that meet the 340B patient definition
46 Apexus Answers Which outpatient facilities are hospitals required to register on the 340B database?
47 Recertification*: Entities are required to recertify information in the HRSA 340B database annually HRSA sends a notification to Authorizing Official and Primary Contact The Authorizing Official performs the recertification online
48 Recertification Statements*: Database entry is complete, accurate, correct Entity meets 340B eligibility requirements Compliance with 340B requirements/restrictions Maintenance of auditable records Systems in place to ensure compliance Contract pharmacy compliance, entity obtains sufficient information Entity contacts OPA for any breach of the above Entity acknowledges possibility of payment to manufacturers for failure to notify OPA in timely fashion
49 Review Updates sent to OPA during its registration period of October 1-October 15 will be reflected on the OPA database and active as of: a) January 1 b) October 1 c) April 1 d) July 1
50 Review In order to be 340B eligible, outpatient clinics of hospitals must: a) Be listed as reimbursable on the most recently filed cost report b) Must be an integral part of the hospital c) Adhere to all 340B guidelines (i.e. patient definition, etc.) d) All of the above
51 Entities Take Action 1. If you have never seen your entity s record on the OPA database, visit the site, review the record and ensure it is accurate. 2. Identify all potentially eligible 340B areas of your entity; determine if your entity has implemented 340B in all areas that are eligible. 3. For hospitals only: talk to your CFO about the cost report worksheets discussed in this session, and ensure the CFO understands that changes to information on these forms may impact 340B eligibility.
52 4. THE PRIME VENDOR PROGRAM
53 Apexus Focus TEAMWORK Contract Services TEACHING 340B University & 340B OnDemand TRUTH Apexus Answers Call
54 Teamwork: Contracted Supplier Agreements (by year) 120 C o n t r a c t s
55 Teaching: 340B University National experts share leading practices at this one or two day live educational program Aligned with HRSA policy, compliance-focused Only HRSA-endorsed compliance training CE for pharmacists and technicians offered Interactive, opportunities to network, leave with tools to equip your entity 10+ Sessions in 2014 Online, on-demand modules under development
56 Truth: Apexus Answers National 340B source of truth, communicates HRSA policy Staff in constant communication with HRSA to ensure messaging is consistent FAQs available here: Average monthly interactions ~2,000 Tiered levels of response: can handle from basic to complex
57 5. 340B PROGRAM RULES
58 Forces Impacting OPA 340B Participants (Entities and Manufacturers) Advocacy 340B Stakeholders* OPA Government (OIG, GAO, CMS, etc.)
59 Why 340B is like an onion
60 340B Policy Options* Policy Releases Guideline Regulation Statute
61 Do you see a musician or a woman s face?
62 340B Policies* Guidelines Patient Definition* Contract Pharmacy* Audits* Dispute Resolution* Outpatient Facilities Duplicate Discounts* Regulations (proposed**) Manufacturer Civil Monetary Penalties** Administrative Dispute Resolution** Orphan Drugs*
63
64 Major 340B Compliance Areas 1. Duplicate Discount Prohibition* 2. No Diversion (Patient Definition)* 3. Certain Hospitals Only Group Purchasing Organization (GPO) Prohibition* Orphan Drug Exclusion
65 Duplicate Discount Prohibition 340B Price Medicaid Rebate
66 Preventing Duplicate Discounts
67 Patient Definition* Records of individual s care Health care services, health care professional Employed by, under contractual or other arrangements (referral) Entity has responsibility for care Service received is consistent with funding or designation status (hospitals exempt) Services must be more than dispensing Aids Drug Assistance Program (ADAP) exception
68 GPO Prohibition* Applies to: Disproportionate Share Children s Hospitals Free Standing Cancer Hospitals Such hospitals:...will not participate in a group purchasing organization or group purchasing arrangement for covered outpatient drugs as of the date of this listing on the OPA website. OPA GPO Certification Form
69 Orphan Drug Exclusion Final Rule Published July 23, 2013, effective October 1, 2013 Free-standing cancer hospitals, Rural Referral Centers, Sole Community Hospitals, and Critical Access Hospitals Excluded from 340B: drugs used for the indication for which they received an orphan designation but not when the drug is used for indications independent of that designation Both HRSA and manufacturers may audit this exclusion OPA published the orphan drug list here in 9/2013: Lawsuit filed from PhRMA 9/27/13
70 Entities Take Action 1. Apply the brief tool 340B Compliance Self- Assessment Policy to your entity type 2. Review FAQs on specific policy topics for more information 3. Contact Apexus Answers to help you resolve any questions or concerns
71 Takeaways 1. The intent of 340B: to support entities that serve vulnerable patients so the entities stay in business 2. Major 340B stakeholders: federal government, certain drug manufacturers, certain covered entities, 340B Prime Vendor Program, managed by Apexus 3. Covered entities must register on the HRSA Database; once a year they must recertify accuracy of HRSA 340B database information
72 Takeaways 4. The 340B Prime Vendor Program provides: Truth (call center) Teamwork (contracting with distributors and suppliers) Teaching (340B University) 5. Covered entities must maintain auditable records: Only patients of the covered entity receive 340B drugs A Medicaid rebate is not paid on a 340B drug All eligibility criteria are met
73 Tips for Pharmacy Technicians Remind leadership they are not required to log in to the HRSA 340B database for change forms or to view profiles Check your 340B standard operating procedures to make sure they reflect your entity s operations If a new location/contract pharmacy are added to the HRSA database, remember the quarterly deadlines Keep the contact number for Apexus Answers handy
74 Questions
75 SESSION 1: THE TOP 5: 340B BASICS FOR NON-HOSPITALS Debra Demers
76 Objectives 1. Define the intent of the 340B program 2. Describe the major 340B stakeholders 3. Explain how to participate in 340B 4. Identify how the 340B Prime Vendor Program supports 340B stakeholders 5. List the program rules and explain how to follow them
77 Takeaways 1. The intent of 340B: to support entities that serve vulnerable patients so the entities stay in business 2. Major 340B stakeholders: federal government, certain drug manufacturers, certain covered entities, 340B Prime Vendor, managed by Apexus 3. Covered entities must register on the HRSA Database; once a year they must recertify accuracy of HRSA 340B database information
78 Takeaways 4. The 340B Prime Vendor Program provides: Truth (call center) Teamwork (contracting with distributors and suppliers) Teaching (340B University) 5. Covered entities must maintain auditable records: Only patients of the covered entity receive 340B drugs A Medicaid rebate is not paid on a 340B drug All eligibility criteria are met
79 1. 340B PROGRAM INTENT AND OVERVIEW
80 340B Intent To permit covered entities to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. H.R. Rep. No (II), at 12 (1992)
81 Share Which examples below describe 340B program savings used in alignment with 340B program intent? Discuss at your table. a) Supporting an indigent care clinic b) Starting a patient assistance medication program c) Subsidizing medications for patients unable to pay d) Adding pharmacy staff
82 340B Statute Resulted from a 1992 federal statute Manufacturers participating in Medicaid Drug Rebate Program must sign a Pharmaceutical Pricing Agreement (PPA) with the Secretary of Health and Human Services The manufacturer agrees to charge a price for covered outpatient drugs that does not exceed the 340B price
83 340B Price Calculated quarterly 340B ceiling price = Average Manufacturer Price (AMP) Medicaid Unit Rebate Amount (URA) Manufacturer submits data to CMS
84 Relative Pricing 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 100% 79% 66% 64% 58% 53% Private Sector Pricing 51% 49% 42% Adapted from a slide by Safety Net Hospitals for Pharmaceutical Access Source: Data derived from Prices for Brand-Name Drugs Under Selected Federal Programs, Congressional Budget Office (June 2005)
85 340B Covered Outpatient Drugs* Vaccines Inpatient drugs Drug not directly reimbursed FDA doesn t require NDC Outpatient Prescription Drugs Over-the-counter drugs (with a prescription) Clinic administered drugs Biologics Insulin
86 Program Evolution Access Sub-Regulatory Integrity Regulatory
87 Have you been here?
88 340B Program Integrity Manufacturer Calculate and charge a correct 340B price Subject to HRSA audits Entity Comply with 340B statute and guidelines Subject to HRSA and manufacturer audits OPA Program Integrity Page:
89 Concerns from Peers I m afraid I ll have an audit and not be aware of a particular aspect of the program, even though I ve tried to stay on top of everything. I worry about how to apply certain policies; it seems that there are different interpretations of the right thing to do.
90 Share Please share your primary 340B program integrity concern with the person sitting next to you.
91 Review Which of the following is a 340B covered outpatient drug? a) Vaccine b) Inpatient drugs c) Over the counter drug not prescribed in writing by an authorized provider d) None of the above are covered outpatient drugs
92 Entities Take Action 1. Describe how your entity s use of the 340B program supports the intent of the 340B program. 2. Identify how your entity can document the use of 340B savings to align with the intent of the 340B program. 3. Incorporate these elements into your 340B related standard operating procedures. 4. Rely on trusted resources identified by OPA as the source of truth for 340B issues: OPA and Apexus.
93 2. MAJOR 340B STAKEHOLDERS
94 Major 340B Stakeholders Manufacturer Calculate Entity and offer Provide 340B price 340B access OPA Administer 340B program 340B Drug to Patient
95 HRSA Office of Pharmacy Affairs (OPA) Health Resources and Services Administration (HRSA) Oversees 340B Program administration (enrollment, recertification, compliance) Establishes mechanism to prevent duplicate discounts OPA support The 340B Prime Vendor Program, managed by Apexus Apexus is not the same thing as HRSA; Apexus communicates HRSA policy
96 HRSA-Endorsed Resources HRSA Apexus
97 340B Eligible Entities* Federal Grantees/Designees Federally Qualified Health Center Federally Qualified Health Center Look-Alikes Title X Family Planning Grantees State Aids Drugs Assistance Programs Ryan White Care Act Grantees (A,B,C,D,F) Black Lung Clinics Hemophilia Treatment Centers Native Hawaiian Health Centers Urban Indian Organizations Sexually Transmitted Disease Grantees Tuberculosis Grantees Certain Hospitals Disproportionate Share Hospitals Children s Hospitals Critical Access Hospitals Free Standing Cancer Hospitals Rural Referral Centers Sole Community Hospitals
98 3. PARTICIPATION IN 340B
99 To Participate in 340B, an Entity must 1. Ensure it has the capability to follow (and maintain auditable records documenting compliance with) program rules 2. Register on the HRSA 340B Database 3. Recertify with HRSA annually
100 HRSA 340B Database* The HRSA 340B Database is the official source of 340B information Entities* Contract Pharmacies* Manufacturers Medicaid Exclusion File*
101 340B Database: 340B Statistics 340B database: APR ,196 registered sites: 11,718 are hospital sites 14, 485 unique contract pharmacies >$7.5B/year in 340B drug purchases ~82% of 340B participants enrolled with Apexus
102 340B Database: 340B Statistics, continued APR % of covered entity sites utilize contract pharmacies 89% of covered entity sites use only in-house or inhouse and one contract pharmacy Of sites using contract pharmacy, 73% have five or fewer contract pharmacy arrangements
103 Working with the HRSA 340B Database Entities DO NOT need to log into the 340B database All links referenced on the homepage are accessible without a username & password
104 Working with the HRSA 340B Database When searching for your covered entity s profile - LESS IS MORE The 340B ID is the most reliable search criteria
105 Working with the HRSA 340B Database Covered entity data is divided between tabs on the 340B profile The information about your facility can be found under the applicable tabs
106 HRSA 340B Database: Medicaid
107 Working with the HRSA 340B Database Important Notifications & What s New o Great resource for important notifications about: Registration Recertification Change requests Database changes
108 Registration Process* New entities, entity sites, contract pharmacies, Medicaid information 2 week registration periods, quarterly updates made to OPA Database Update Official October 1 January 1 April 1 July 1 Registration Period July 1 15 October 1-15 January 1 15 April 1-15 Change requests: changes to existing information, rolling basis
109 Electronic Handbook HRSA/OPA uses it for validation of site information EHB data incorporated as part of recertification in FEB 2014 Importance of EHB changes and timing, especially changes of scope Possibility of chargeback denial and/or wholesaler delivery issues if EHB doesn t match HRSA and entity s wholesaler information
110 Apexus Answers A CHC uses employed healthcare professionals to provide elderly care services at a non-entity owned clinic. The CHC owns the records of care. Should the CHC register this location on the 340B database? Is 340B use permissible?
111 Recertification*: Entities are required to recertify information in the HRSA 340B database annually HRSA sends a notification to Authorizing Official and Primary Contact The Authorizing Official performs the recertification online
112 Recertification Statements*: Database entry is complete, accurate, correct Entity meets 340B eligibility requirements Compliance with 340B requirements/restrictions Maintenance of auditable records Systems in place to ensure compliance Contract pharmacy compliance, entity obtains sufficient information Entity contacts OPA for any breach of the above Entity acknowledges possibility of payment to manufacturers for failure to notify OPA in timely fashion
113 Review Updates sent to OPA during its registration period of October 1-October 15 will be reflected on the OPA database and active as of: a) January 1 b) October 1 c) April 1 d) July 1
114 Entities Take Action 1. If you have never seen your entity s record on the OPA database, visit the site, review the record and ensure it is accurate 2. Identify all potentially eligible 340B areas of your entity; determine if your entity has implemented 340B in all areas that are eligible
115 4. THE PRIME VENDOR PROGRAM
116 Apexus Focus TEAMWORK Contract Services TEACHING 340B University & 340B OnDemand TRUTH Apexus Answers Call
117 Teamwork: Contracted Supplier Agreements (by year) 120 C o n t r a c t s
118 Teaching: 340B University National experts share leading practices at this one or two day live educational program Aligned with HRSA policy, compliance-focused Only HRSA-endorsed compliance training CE for pharmacists and technicians offered Interactive, opportunities to network, leave with tools to equip your entity 10+ Sessions in 2014 Online, on-demand modules under development
119 Truth: Apexus Answers National 340B source of truth, communicates HRSA policy Staff in constant communication with HRSA to ensure messaging is consistent FAQs available here: Average monthly interactions ~2,000 Tiered levels of response: can handle from basic to complex
120 5. 340B PROGRAM RULES
121 Forces Impacting OPA 340B Participants (Entities and Manufacturers) Advocacy 340B Stakeholders* OPA Government (OIG, GAO, CMS, etc.)
122 Why 340B is like an onion
123 340B Policy Options* Policy Releases Guideline Regulation Statute
124 Do you see a musician or a woman s face?
125 340B Policies* Guidelines Patient Definition* Contract Pharmacy* Audits* Dispute Resolution* Outpatient Facilities Duplicate Discounts* Regulations (proposed**) Manufacturer Civil Monetary Penalties** Administrative Dispute Resolution** Orphan Drugs*
126
127 Major 340B Compliance Areas 1. Duplicate Discount Prohibition* 2. No Diversion (Patient Definition)* 3. Certain Hospitals Only Group Purchasing Organization (GPO) Prohibition* Orphan Drug Exclusion
128 Duplicate Discount Prohibition 340B Price Medicaid Rebate
129 Preventing Duplicate Discounts
130 Patient Definition* Records of individual s care Health care services, health care professional Employed by, under contractual or other arrangements (referral) Entity has responsibility for care Service received is consistent with funding or designation status (hospitals exempt) Services must be more than dispensing Aids Drug Assistance Program (ADAP) exception
131 Entities Take Action 1. Apply the brief tool 340B Compliance Self- Assessment Policy to your entity type 2. Review FAQs on specific policy topics for more information 3. Contact Apexus Answers to help you resolve any questions or concerns
132 Takeaways 1. The intent of 340B: to support entities that serve vulnerable patients so the entities stay in business 2. Major 340B stakeholders: federal government, certain drug manufacturers, certain covered entities, 340B Prime Vendor, managed by Apexus 3. Covered entities must register on the HRSA Database; once a year they must recertify accuracy of HRSA 340B database information
133 Takeaways 4. The 340B Prime Vendor Program provides: Truth (call center) Teamwork (contracting with distributors and suppliers) Teaching (340B University) 5. Covered entities must maintain auditable records: Only patients of the covered entity receive 340B drugs A Medicaid rebate is not paid on a 340B drug All eligibility criteria are met
134 Tips for Pharmacy Technicians Remind leadership they are not required to log in to the HRSA 340B database for change forms or to view profiles Check your 340B standard operating procedures to make sure they reflect your entity s operations If a new location/contract pharmacy are added to the HRSA database, remember the quarterly deadlines Keep the contact number for Apexus Answers handy
135 Questions
136 SESSION 2: 340B PRICING Chris Hatwig Chris Shain George Kenny
137 Objectives Identify the activities of the manufacturer and wholesaler in 340B pricing Explain 340B price calculation for covered outpatient drugs Discuss the manufacturer and wholesaler perspectives on policy issues
138 Takeaways Manufacturers and wholesalers have important roles in supporting program integrity Manufacturers have 340B compliance responsibilities The 340B price file is one of the most complex Actions entities take can impact a manufacturer s calculations and ultimately impact the manufacturer s compliance
139 Panel Question What are the 340B-related roles and responsibilities for you and your organization?
140 Manufacturer: Role/Responsibilities Uphold responsibilities in the Pharmaceutical Pricing Agreement Calculate and charge a correct PHS Price Ensure that you charge the price to valid 340B entities Validate customers on indirect sales (chargebacks) to the OPA database (eligibility)
141 Pharmaceutical Pricing Agreement HRSA Responsibilities Public list of 340B entities, including Medicaid information Require entities to maintain purchasing/dispensing records for covered outpatient drugs and Medicaid reimbursement for these drugs for not less than 3 years Manufacturer Responsibilities Charge 340B entities a price that does not exceed the 340B ceiling price Retain necessary records for not less than 3 years from date of creation Afford Secretary (or designee) reasonable access to records relevant to compliance Permit CMS to share AMP and URA with Secretary in order to carry out agreement Participate with HRSA 340B Prime Vendor Program (voluntary)
142 Wholesaler: Role/Responsibilities Open accounts with only eligible entities Deliver correct price to 340B entities Process chargebacks with manufacturer correctly
143 Manufacturer Question How is the 340B price calculated?
144 Manufacturer: 340B Calculation 340B Price based on quarterly Medicaid metrics which are based on commercial contracting practices AMP: Average Manufacturer Price Weighted average price (net of discounts) to retail community pharmacies BP: Best Price Lowest price to US customers, certain federal pricing, such as 340B, excluded URA: Unit Rebate Amount Brand: Greater of [(AMP * 231%) or (AMP BP)] plus inflation penalty Generic/OTC: 13% of AMP
145 Manufacturer: 340B Calculation 340B Ceiling Price WAC AMP minus URA equals 340B Unit Price BP times Units per Package equals 340B Ceiling Price
146 Manufacturer: 340B Implementation Quarterly Pricing 340B prices change quarterly Manufacturers upload to authorized wholesalers days prior to beginning of a quarter 340B pricing lags behind Medicaid by 2 quarters Q1 Q2 Q3 Sales transactions occur Q1 AMP and BP calculated, submitted to CMS; 340B ceiling price calculated, submitted to wholesalers 340B ceiling price becomes effective (based on Q1 transactions)
147 Apexus Answers Why is my 340B price different from another 340B entity s price?
148 Panel Question How do you implement a chargeback?
149 Manufacturer: Chargeback Process B price is established 2. Wholesaler purchases at WAC ($10) 3. Covered entity places 340B order with wholesaler 4. Wholesaler reviews OPA database, then sells to covered entity at 340B price ($6) 5. Wholesaler sends manufacturer a 340B chargeback ($4) 6. Manufacturer verifies 340B eligibility of covered entity (reviews OPA database) 7. Manufacturer pays wholesaler the chargeback Potentially significant Medicaid implications if a manufacturer provides the 340B price to a non-participating entity
150 Manufacturer: Chargeback Comments Manufacturer MUST validate entity on the chargeback to confirm 340B eligibility Manufacturer will deny the chargeback if they can not validate eligibility Bill-to address on the chargeback identifies eligibility Correct information is critical
151 Wholesaler: Chargeback Comments B Pricing changes quarterly: Unique and Challenging 340B is the most challenging price file to administer in the pharmaceutical industry 2. No verified central file of all 340B pricing Wholesale distributors receive more than 100 different notices from manufacturers, 4 times per year PVP does provide a comparative price file to Participants which shows the Big 3 and one regional wholesaler s 340B pricing for comparison
152 Wholesaler: Chargeback Comments 3. Contract Pharmacy and Entity Identification: HIN, DEA, 340B ID 4. Returns: The correct invoice must be chosen when returning a product
153 Manufacturer Question What types of adjustments do manufacturers make to prices?
154 Manufacturer: Pricing Adjustments Standard procedures Routine Medicaid restatements Standard Best Price true-ups Medicaid restatements resulting from audits/investigations Reclassification/banking
155 Apexus Answers What steps does an entity take to resolve what it believes to be an incorrect 340B price?
156 Apexus Answers What is the procedure used by manufacturers that wish to refund payment to covered entities who are overcharged for 340B?
157 Panel Question What are special situations or challenges for you specific to 340B?
158 Manufacturer: Special Situations Penny pricing Sub-Ceiling prices (voluntary) Through 340B Prime Vendor Program (non-famp exempt) Not through 340B Prime Vendor Program (include in non-famp) Inpatient pricing Product allocation systems 340B customers can be subject to product allocation systems just like commercial customers Non-discrimination guidance Timing issues Concern about hoarding
159 Apexus Answers If a drug is only available through a specialty pharmacy, how would a 340B patient access that drug?
160 Wholesaler: Contract Pharmacy Challenges Complex 340B contract pharmacy relationships present additional challenges Manufacturer requirements are not consistent regarding 340B sales reporting for 340B contract pharmacy Process: 1. Confirm accurate bill-to 340B covered entity and ship-to (contract pharmacy) information specific to the relationship on the OPA website 2. Request HIN (5-7 business days) 3. Account Set Up (Multi-Ship To Form/Customer Application) 4. Set ordering/delivery options 5. Covered Entity Authorization 6. Complete Credit Application if new customer 7. Verify licenses, CSMP setup 8. Set up EDI specific to 340B vendor
161 Entities Take Action Keep OPA database information accurate/current to avoid chargeback issues Check the OPA website for manufacturer updates
162 Takeaways Manufacturers and wholesalers have important roles in supporting program integrity Manufacturers have 340B compliance responsibilities The 340B price file is one of the most complex Actions entities take can impact a manufacturer s calculations and ultimately impact the manufacturer s compliance
163 Tips for Pharmacy Technicians Remember: you have resources to check pricing! Log in to the Apexus 340BPVP.com website to verify pricing, run customized reporting, and keep up-todate with new contracts Communicate pricing changes to leadership; significant price changes may impact purchasing decisions
164 Questions
165 SESSION 3: 340B IMPLEMENTATION Todd Karpinski
166 Objectives Describe 340B delivery models: Contract Pharmacy In-House Pharmacy Mixed-Use Areas Discuss implementation strategies of compliant programs
167 340B Pharmacy Options
168 Pharmacy Options Mixed-Use Single Contract Pharmacy Services Contract Pharmacy In-house Pharmacy Contracty Multiple Contract Phcy Supplement with Contract Clinic Administered Drugs Other Central Fill, Telepharmacy or Specialty Pharmacy
169 Share 1. Your current model for getting 340B drugs to patients 2. One thing you are interested in expanding or changing about your current 340B model
170 CONTRACT PHARMACY
171 Froedtert Hospital 550 bed academic medical center 24,000 annual admissions >140,000 patient days Disproportionate share hospital 17.25% (FY2011) Affiliated with Medical College of Wisconsin Only Level I trauma center in Southeastern Wisconsin Major referral center: 40 specialties and subspecialties >220 Pharmacy FTE s Administration, Pharmacists, Technicians, EPIC team
172 Affiliation with the Medical College of Wisconsin Froedtert Hospital is the major teaching affiliate of the Medical College of Wisconsin (the Medical College ) A majority of Froedtert Hospital s medical staff is comprised of Medical College faculty members (816 faculty) 330 full-time equivalent residents at Froedtert Hospital 413 medical students Close working affiliation between the two organizations Froedtert Hospital and the Medical College jointly operate and own a network of clinical sites for primary care and outpatient clinical initiatives
173 Froedtert Pharmacy Fun Facts Inpatient 3,700 orders per day; 12,000 total doses dispensed daily; 4.3 million doses yearly 2,000 admission histories per month Discharge reconciliation and education Hospital Outpatient Departments (HOD) 70,000 doses dispensed yearly 60,000 injection/iv dispenses yearly Over 30 Ambulatory Clinics Outpatient Pharmacies 170,000 prescriptions/year
174 How do we support the intent of the 340B program? Froedtert Hospital s community benefit framework is to improve the quality of life in the communities we serve through health care programs and services that are measureable, accessible and culturally appropriate; recognizing the greatest impact is in Milwaukee s underserved, urban population. The Setting: US 2010 Census: Milwaukee is #4 in poverty among nation s cities In Milwaukee County, 30% are on Medicaid and 15% are uninsured Our Investments in 2011: $34 million uncompensated care $41 million in government shortfalls Over 10,000 patient accounts adjusted for charity care $400,000 annual support to FQHC s and a $2 million pledge for capital support Over $58 million in health professions education, including college and high school scholarships/internships for underrepresented students
175 Community Benefit from Pharmacy Charity Care Medication Management Home Delivery Diabetes Smart Start Program Medication Collection Program Sharps Collection Program Medication Repository Discharge Program (implemented 9/2011) Ambulatory Care pharmacists Blood pressure cuffs (Newly Transplanted Patients)
176 Froedtert Hospital 340B Timeline AUDIT
177 Takeaways Do not outsource your 340B compliance responsibilities to another party Entities can negotiate the terms of their contract pharmacy agreements The intent of 340B is to stretch scarce federal resources as far as possible to help entities and their patients
178 340B Contract Pharmacy - Overview HRSA guidance permits entities to partner with outside pharmacies to provide eligible patients with 340B medications Identification via shared patient and provider data Inventory via "Bill To - Ship To wholesale arrangements Entity-Contract Pharmacy relationship types Direct Contracting with Pharmacy Contracting through 340B vendor with Pharmacy
179 What is a 340B Vendor? A company providing 340B contract pharmacy program implementation and management Not a HRSA requirement Minimizes impact on retail pharmacy workflow Collects data from retail pharmacy at the switch Provides the interface to identify eligible claims (matches entity data and pharmacy data) Manages inventory replenishment Establishes contracts with pharmacies Provides reports and transparency for auditing
180 340B Contract Pharmacy 1. Contract Pharmacy dispenses drug (non-340b inventory) to 340B entity s eligible patient 2. When a full package size of the Rx is reached, the pharmacy or vendor orders a 340B drug to replace it 3. Replacement 340B drugs are billed to the entity and shipped to the contract pharmacy 4. Entity pays contract pharmacy for its services
181 340B Contract Pharmacy - Data Eligibility data feeds sent 2. Patient presents Rx to pharmacy (or entity sends electronically to pharmacy) 3. Pharmacy submits claim via switch 4. Switch communicates with PBM 5. Claim payer eligibility sent 6. Periodic 340B eligibility determination 7. Periodic 340B replenishment order placed B replenishment order shipped
182 340B Contract Pharmacy - Financial Patient receives Rx, pays co-copay 2. PBM pays pharmacy (3rd party) 3. Pharmacy keeps dispensing fee, pays vendor entity s 3rd party collections 4. Vendor pays entity 3rd party collections, less vendor administrative fees B replenishment order paid
183 Reality of the Complexity
184 Apply It: Patient/Prescriber Data Updates Scenario 1: Pharmacy will update the patient and prescriber data once monthly, per data receipt from entity Is this frequency of updating appropriate? What kinds of data files could the entity use as sources for eligible prescribers/patients?
185 Apply It: Prescriber Eligibility Scenario 2: Prescriber eligibility is determined by a match to a prescriber eligibility list Is this enough? What additional information could be used?
186 Apply It: Fees Scenario 3: Self-Pay: Pharmacy shall collect and receive a $15 dispensing fee and a $1 administrative fee from patient Insured: Pharmacy shall collect and retain 30% of the contracted rate + a $19 dispensing fee Dispensing Fee: rates will increase according to the consumer price index yearly Is this a reasonable fee structure? Does this align with 340B program intent?
187 Apply It: MCO Medicaid Scenario 4 The contract will include patients with Private Insurance. Contract Definitions of Private Insurance Private Insurance includes Managed Care Medicaid Plans. 1. How can you find out if your state collects Medicaid rebates on MCO drugs? 2. If your state collects rebates on MCO drugs, is this language appropriate to include in the contract?
188 Contract Pharmacy Reimbursement Cash Pay/Sliding Fee Reduced pricing at contract pharmacy Private Insurance Medicaid - Managed Care Medicaid Plans Check with your state Entity risk
189 C-Suite Myths This program runs it self! 340B program coordinator / manager essential The first company that approach us is the best/ only one out there! Have the conversation first We have to jump on every opportunity! Be vigilant when considering any opportunity
190 HOW DO WE STAY COMPLIANT?
191 340B Program Coordinator Responsible for day to day program maintenance Preforming compliance audits Maintaining provider list Coordinating data sharing Reporting metrics Assisting in staff training
192 Contract Pharmacy Compliance Audit 1: Patient Eligibility From the vendor s report, choose 20 patients to audit. Select patients who are filling the prescription for the first time. Select patients that have multiple first fills prescriptions written by different prescribers. Verify each patient in EPIC to ensure visit was completed by an eligible provider. Completed daily Audit 2: Hardcopy Prescription Request Request 20 prescription hardcopies from vendor. Verify patient and provider eligibility. Verify that dispenses were accumulated appropriately. Completed monthly
193 Contract Pharmacy Compliance cont d Audit 3: Vendor Prescriber Audit Evaluate each provider used to dispense 340B eligible prescriptions for inclusion on eligible provider list. Eligibility is based on NPI number. Updated provider eligibility list is sent each month Completed monthly
194 Lessons Learned Understand Work with national organizations Network with other covered entities Utilize internal resources Be proactive Review and understand Polices & Procedures Review audit process with key stakeholders Stay engaged Continue to measure and test compliance
195 Contract Negotiation, Summary Entity pays flat fee per claim Stop-loss function (prevents 3rd party transmission if loss to entity) Entity does not pay fees on claim reversals (net paid claims) Entity pays lowest of U&C, MAC, and 340B Entity has access to ALL data (including prescriptions presented vs. filled with 340B) High complexity data management systems HL7 interface Entity pays fees based on % of revenue or drug cost Entity does not keep 3 rd party reimbursement Vendor recruits patients to its mail order pharmacy Early cancellation fees Entity not permitted to select wholesaler Entity may end up purchasing partial bottles at high rates due to nonreplenishment Entity not permitted to contract with other 340b vendors
196 Entities Take Action
197 Takeaways Do not outsource your 340B compliance responsibilities to another party Entities can negotiate the terms of their contract pharmacy agreements The intent of 340B is to stretch scarce federal resources as far as possible to help entities and their patients
198 Questions Take a deep breath, take a good look, and take responsibility.
199 MIXED-USE: GPO Mike Benedict Fern Paul-Aviles Rob Nahoopii
200 Carolinas Medical Center Disproportionate Share Hospital 874-bed Level I Trauma Center in Charlotte, NC 2 infusion centers: 1 cancer, 1 non-cancer Behavioral Health Center Five outpatient retail pharmacies located in clinic buildings that provide primary care and behavioral health care
201 Carolinas Medical Center Resources within Pharmacy for 340B compliance Dedicated Enterprise audit tech (former buyer) shared among 7 facilities Enterprise 340B Director Facility Directors of Pharmacy Materials management department Inventory management software, automated dispensing machines, split-billing software and HIS system Wholesaler account representative and other wholesaler experts
202 Panel Question Describe what data you feed into your splitbilling software and the source for that data
203 Use of 340B Savings Offer meds on a sliding scale to indigent patients and numerous patient assistance programs Ambulatory clinical pharmacy services in anticog, HIV, asthma, diabetes (appropriate care) Carolinas Medical Center 340B Savings Built a primary care clinic within Behavioral Health Center using Family Medicine fellow Multidisciplinary care teams (RN, CM, PharmD, Health Advocate) to prevent readmissions
204 Use of 340B Savings 340B Charity Care Voucher Program Diabetes Clinic Family Practice Clinic Synagis (palivizumab) Clinic Pertussis Cocooning Clinic Discharge Medication Support (Cath Pts)
205 Takeaways 1. Carefully consider which options you elect if using split billing software 2. Take steps to minimize your WAC spend 3. Load correct contracts, including Apexus sub- WAC pricing 4. Define: inpatient, outpatient 5. Interpret: covered outpatient drug 6. Account: for waste and lost charges
206 Overview: Mixed-Use Mixed-Use Setting in a Nutshell In a mixed-use area, the entity dispenses/administers medications to both inpatients and outpatients from the same location (pharmacy) Examples Cardiac Cath Lab, One-day surgery, Emergency Department, Endoscopy
207 GPO Prohibition* Applies to: Disproportionate Share Children s Hospitals Free Standing Cancer Hospitals Such hospitals:...will not participate in a group purchasing organization or group purchasing arrangement for covered outpatient drugs as of the date of this listing on the OPA website. OPA GPO Certification Form
208 Entities Must Ensure 340B is limited to OUTPATIENTS Patients meet patient definition Patient status = outpatient (at time of service) Prescriber = eligible prescriber Location of service = reimbursable on cost report, registered on 340B database (if req.) No GPO use for covered outpatient drugs for DSH/PEDs/CAN No duplicate discounts on Medicaid transactions
209 Split-Billing Software to the Rescue There is one physical drug inventory serving both inpatients and outpatients This software merges data from patient visits (date/time of service, patient status, prescriber, location/clinic, Medicaid status) to help split orders into the right buckets
210 Accumulators and Eligibility Accumulator: GPO Accumulator/Default: Non-GPO/WAC Accumulator: 340B Inpatients 340B ineligible outpatients 340B eligible outpatients Medicaid carve-out Lost charges Clinics within 4-walls but not 340B eligible In-house pharmacy open to public
211 Wholesaler Account Setup -DSH/PED/CAN with GPO Prohibition Inpatient GPO GPO Contract DSH Inpatient GPO Contracts (DSH only) GPO or Wholesaler Generic Source Program Individual Hospital Agreement Outpatient (not 340B eligible) Non-GPO/WAC WAC Pricing PVP Sub-WAC (if enrolled in PVP) Apexus Generic Portfolio (AGP) (if enrolled in PVP) Individual Hospital Agreement (single entity only) Outpatient (340B eligible) 340B PHS/340B PVP Sub-340B (if enrolled in PVP) Apexus Generic Portfolio (AGP) (if enrolled in PVP) Individual Hospital Agreement (single entity only)
212 Update: Account Load Options
213 Contracting: Avoid These Pitfalls The following situations are not GPO-compliant contracting practices: - An individual DSH accessing contracts executed by a network (i.e. IDN, ACO, etc.) in which it is a member - A wholesaler s generic source program (unless offered as a subcontracted solution to the Apexus Generics Source portfolio) - A manufacturer extending a discounted price to a group of covered entities (subject to the GPO prohibition) through a wholesaler, other third party or group purchasing arrangement, that is not supported by an individual contract between the 340B covered entity and the manufacturer. Such agreements should be reproducible for review during an audit of compliant 340B
214 GPO: Special Situations GPO private label products IVIG Drug shortages
215 2 Key Questions HRSA Will Ask: What outpatient accounts do you have? How do you purchase drugs for ineligible outpatients?
216 Panel Question What is the biggest challenge for you regarding record-keeping/inventory management?
217 Mixed-use Inventory/Record Keeping Challenges Steps to take Pitfalls to avoid Example
218 Minimizing WAC Exposure Tool
219 Panel Question Please share a few strategies to minimize WAC exposure
220 Strategy #1: Covered Outpatient Drug Q: Can a hospital subject to the GPO Prohibition use a GPO for drugs that are part of/incident to another service and payment is not made as direct reimbursement of the drug ( bundled drugs )? A: If the entity interprets the definition of covered outpatient drug referenced in the 340B Statute (Social Security Act 1927 (k)) and decides that bundled drugs do not meet this definition, a GPO may be used for drugs that are not covered outpatient drugs. The decision the entity makes should be defensible, consistently applied in all areas of the entity, documented in policy/procedures, and auditable.
221 Strategy #2: GPO Only Clinics In certain off-site outpatient hospital facilities that meet all of the following criteria: 1. Are located at a different physical address than the parent; 2. Are not registered on the OPA 340B database as participating in the 340B Program; 3. Purchase drugs through a separate pharmacy wholesaler account than the 340B participating parent; and 4. The hospital maintains records demonstrating that any covered outpatient drugs purchased through the GPO at these sites are not utilized or otherwise transferred to the parent hospital or any outpatient facilities registered on the OPA 340B database.
222 Strategy #3: Waste/Lost Charges Expired/returns-return company policy, entity policy Waste/lost charges Multi-dose vials, insulin Mixed product, but patient doesn t get dose
223 Strategy #4: Charge Code to NDC Charge code to the correct NDC Charge quantity to the package size Procrit, e.g. Billing unit: 1000 units Vial size: 20,000 units/1 ml vial Package size: 4 vials per box How many billing units per package?
340B UNIVERSITY San Francisco Edition. February 3-4, 2015
340B UNIVERSITY San Francisco Edition February 3-4, 2015 WELCOME TO 340B UNIVERSITY! About Apexus The mission of Apexus is to leverage our unique resources and expertise to deliver maximum value to 340B
More information4/3/2015 WHAT IS 340B? DISCLOSURE. No conflicts of interest to disclose
WHAT IS 340B? S C O T T M I L N E R P H AR M D, M B A DISCLOSURE No conflicts of interest to disclose 1 OBJECTIVES At the end of this presentation we should be able to: Describe the origin of the 340b
More information340B Drug Discount Program Overview and Emerging Issues
340B Drug Discount Program Overview and Emerging Issues I. APPLICABLE STATUTE AND OTHER LEGAL AUTHORITIES Section 340B of the Public Health Service Act (42 U.S.C. 256b) requires pharmaceutical manufacturers,
More information10/1/2013. Objectives. 340B Drug Pricing Program; Transitioning from Access to Integrity. 340B Stats, Arkansas. 340B Participating Entities, AR
Objectives Drug Pricing Program; Transitioning from Access to Integrity Arkansas Association of Health-system Pharmacists 47 th Annual Fall Seminar October 3 & 4, 2013 Chris Hatwig RPh, MS, FASHP President,
More information340B Drug Pricing Program January 15, 2015
340B Drug Pricing Program January 15, 2015 340B Basics - Gary Merchant. MBA, BSPharm 340B Audit - Robert Theriault, MBA, BSPharm Declarations Neither Gary Merchant nor Robert Theriault have no actual or
More informationFederal 340B Drug Pricing Program
2015 CliftonLarsonAllen LLP Federal 340B Drug Pricing Program March 6, 2015 Continuous learning in action Learning Objectives Explain the intent of the Federal 340B Drug Pricing Program List the eligibility
More informationXXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management
340B XXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management 800.473.3516 www.wellpartner.com Table of Contents 340B Fundamentals for Health System Executive Management...1 What
More information340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready. Suzanne Herzog Founding Director Rx X Consulting
340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready Suzanne Herzog Founding Director Rx X Consulting What is 340B? 340B Overview A drug discount program that allows covered
More information2015-340B & Prime Vendor Program Update
2015-340B & Prime Vendor Program Update Christopher A. Hatwig, R.Ph., MS, FASHP President, Apexus 340B Sales by Entity Types Percentage of Total Apexus Participant Sales 90.00% 80.00% 70.00% 60.00% 50.00%
More informationSpeakers. Recent Developments in 340B Drug Pricing Program Compliance and Enforcement. Elizabeth S. Elson, Esq. Anil Shankar, Esq.
1 Recent Developments in 340B Drug Pricing Program Compliance and Enforcement Elizabeth S. Elson, Esq. Anil Shankar, Esq. October 18, 2012 2 Speakers Elizabeth Elson Of Counsel Foley & Lardner LLP Los
More information340B Drug Pricing Program
340B Drug Pricing Program Chad E. Gay Director of Contract Compliance Agenda Discuss the 340B drug pricing program How the program is defined Who is eligible Enrollment Dates to be aware of Source Documentation
More informationThe 3 Keys to Success in Your 340B Program. Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company
The 3 Keys to Success in Your 340B Program Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company Objectives Provide a description and overview of the 340B program Discuss
More informationHRSA Pharmacy Services Support Center: The 340B Access Resource
HRSA Pharmacy Services Support Center: The 340B Access Resource Lisa Scholz PharmD, MBA Vice President, APhA HRSA Pharmacy Services Support Center Office of Population Affairs Webinar 9/16 INTEGRITY ACCESS
More information340B Drug Pricing Program: Overview and Recent Developments
340B Drug Pricing Program: Overview and Recent Developments November 12, 2015 Kirstin B. Ives Partner and Chair of Healthcare Litigation Group Williams Montgomery & John Ltd. 233 S. Wacker Drive, Suite
More information340B Integrity Audit: Is Your Hospital Ready for a HRSA Audit? February 4, 2013
340B Integrity Audit: Is Your Hospital Ready for a HRSA Audit? February 4, 2013 1 Agenda 340B Program Overview Why HRSA Audits? What will HRSA Audits Cover? Verification of Eligibility: Covered Entity,
More information340B University Page 1 Split-Billing Software Considerations Checklist
340B University Page 1 Purpose: The purpose of this tool is to provide a decision checklist for entities to evaluate split-billing software. The tool presents considerations for an entity when selecting,
More informationStatement of Conflicts of Interest
10 th Annual 340B Coalition Winter Conference Expansion of Pharmacy Services Through the 340B Program Binita Patel, PharmD, MS Director of Ambulatory/Retail Services Froedtert & Medical College of Wisconsin
More information340B Drug Discount Program 2013 March 15, 2013 1 Agenda 340B Program Overview Covered Entities Covered Drugs Covered Patients Why HRSA Audits How to Prepare for HRSA Audit Questions/Answers 2 340 DRUG
More informationKeep Your Savings: 340B Audits and Ensuring Compliance
Keep Your Savings: 340B Audits and Ensuring Compliance Disclosure This presentation reflects experience with the topics at hand and does not constitute legal advice, and does not reflect interpretation
More informationEnsuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability
Ensuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability Fern Paul-Aviles, PharmD, MS, BCPS Director, 340B and Ambulatory Regulatory Program Compliance Carolinas Healthcare
More informationThe 340B Drug Pricing Program: The Basics
The 340B Drug Pricing Program: The Basics Paul Shank, MBA Health & Human Services Consultant, Health Resources and Services Administration Healthcare Systems Bureau, Office of Pharmacy Affairs July 14,
More informationThe 340B Drug Pricing Program: The Basics
The 340B Drug Pricing Program: The Basics Todd Lemke, Pharm.D CDE Paynesville Area Health Care System Pharmacist HRSA APhA Pharmacy Services Support Center Consultant 1 Intent of the 340B Program Safety
More information340B Drug Pricing Program. A Survey of the Program s Past, Present, and Future
340B Drug Pricing Program A Survey of the Program s Past, Present, and Future Presented by: Daniel Soldato Wyatt, Tarrant & Combs LLP dsoldato@wyattfirm.com (859) 288-7631 Disclaimer The views expressed
More information340B Compliance: I sure wish I d known that!
340B Compliance: I sure wish I d known that! Aaron K. Lott Pharm. D. Executive Director of Pharmacy Services June 2015 Disclosures The presenter has no significant financial or commercial interests to
More informationThe 340B Drug Discount Program Overview, Compliance Issues and Interplay with Medicare and Medicaid
The Drug Discount Program Overview, Compliance Issues and Interplay with Medicare and Medicaid Barbara Straub Williams Powers Pyles Sutter & Verville PC American Health Lawyers Association 2014 Institute
More informationFinally... maybe? The Long Awaited 340B Mega Guidance. Georgia Healthcare Financial Management Association. October 2015
Finally... maybe? The Long Awaited 340B Mega Guidance Georgia Healthcare Financial Management Association October 2015 Disclaimer This webinar assumes the participant is familiar with the basic operations
More informationDisclosure. Overview. Safety Net Hospitals for Pharmaceutical Access
340B: Issues and Opportunities in Pharmacy Automation Safety Net Hospitals for Pharmaceutical Access Executive Director, SNHPA Editor in Chief, Drug Discount Monitor American Society for Automation in
More informationThe 340B Drug Pricing Program: The Basics INTEGRITY ACCESS VALUE 1
The 340B Drug Pricing Program: The Basics INTEGRITY ACCESS VALUE 1 Learning Objectives 1 2 3 Intent of the program 340B Pricing determination Entity eligibility 4 5 6 Program requirements and prohibitions
More informationThe Pharmacy 340B Program- Compliance & Internal Audit Strategies. for Covered Entities. Matthew D. Vogelien Huron Healthcare
The Pharmacy 340B Program- Compliance & Internal Audit Strategies Matthew D. Vogelien Huron Healthcare for Covered Entities 340B Drug Discount Program (340B Program) Discussion Outline Topics for Discussion:
More informationMEDICARE PART B DRUGS. Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals
United States Government Accountability Office Report to Congressional Requesters June 2015 MEDICARE PART B DRUGS Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals
More informationCPAs and ADVISORS. experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS
CPAs and ADVISORS experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS BRIAN M. BELL BRAD K. BROTHERTON DIRECTOR PARTNER MATERIALS COVERED TODAY 340B Program Evolution, Purpose & Benefits
More informationOverview of the 340B Drug Pricing Program
M a y 2 0 1 5 Report to the Congress Overview of the 340B Drug Pricing Program M a y 2 0 1 5 Report to the Congress Overview of the 340B Drug Pricing Program 425 I Street, NW Suite 701 Washington, DC 20001
More informationThe 340B Program: New Developments and New Opportunities for CAHs and Others. Todd Nova Hall Render
The 340B Program: New Developments and New Opportunities for CAHs and Others Todd Nova Hall Render Wisconsin Office of Rural Health Hospital Finance Workshop August 30, 2011 What We Will Cover 2 340B Program
More informationGAO DRUG PRICING. Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement
GAO United States Government Accountability Office Report to Congressional Committees September 2011 DRUG PRICING Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs
More informationLegal Alert. Long-Awaited 340B Program Guidance Now Available for Comments: What Stakeholders Need to Know. Authors
September 10, 2015 1 Legal Alert Authors Stephanie Trunk Partner stephanie.trunk@arentfox.com Erin E. Atkins Associate erin.atkins@arentfox.com Long-Awaited 340B Program Guidance Now Available for Comments:
More informationMega Guidance Is Here!
Mega Guidance Is Here! David Pointer has no actual or potential conflict of interest in relation to this presentation. 1 Introduction Where are we today? Brief Overview of HRSA Audit Findings Where are
More informationMega Guidance Is Here!
Mega Guidance Is Here! David Pointer has no actual or potential conflict of interest in relation to this presentation. Introduction Where are we today? Brief Overview of HRSA Audit Findings Where are we
More informationThe 340B Drug Discount Program
The 340B Drug Discount Program Ponaman Healthcare Consulting Ralph V. Moreno Jr. Presented: August 11, 2011 Table of Contents...1 THE 340B DRUG DISCOUNT PROGRAM 1.1 340B Overview......2 1.2 340B Eligibility.......
More informationSec. 340B PUBLIC HEALTH SERVICE ACT
Sec. 340B PUBLIC HEALTH SERVICE ACT LIMITATION ON PRICES OF DRUGS PURCHASED BY COVERED ENTITIES (a) REQUIREMENTS FOR AGREEMENT WITH SECRETARY. (1) IN GENERAL. The Secretary shall enter into an agreement
More information340B Drug Discount Program Identifying risks and internal audit focus areas
340B Drug Discount Program Identifying risks and internal audit focus areas Introduction The 340B Drug Discount Program is administered by the Health Resources and Services Administration (HRSA) Office
More information340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY
CPAs & ADVISORS experience clarity // 340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY September 17, 2014 Michael Earls, CPA, Senior Manager September 17, 2014 OVERVIEW OF TODAY S PRESENTATION
More informationC. Covered 340B drugs, as found in section 1927 (k)(2) of the Social Security Act, include the following outpatient drugs:
Title 23: Medicaid Part 200: General Provider Information Part 200 Chapter 4: Provider Enrollment Rule 4.10: 340B Providers A. The Division of Medicaid defines a 340B provider as a nonprofit healthcare
More informationUPDATES ON 340B 2011. Where do we go from here?
UPDATES ON 340B 2011 Where do we go from here? Brief Review of 340B Initiated during Clinton administration Who can participate? (FQHC, Family Planning, Ryan White, Black lung, Hemophilia, Urban Indian,
More information340B PROGRAM. Scrutiny & Uncertainty Increase the Need for Compliance
340B PROGRAM Scrutiny & Uncertainty Increase the Need for Compliance Uncertainty will always be part of the taking charge process. Harold S. Geneen For many years, drug manufacturers and Covered Entities
More informationASHP Regulatory Alert
Proposed Guidance: 340B Drug Discount Program Introduction On Friday, August 28, 2015, the Health Resources and Services Administration (HRSA) published the long awaited proposed omnibus guidance for the
More informationTEXAS VENDOR DRUG PROGRAM PHARMACY PROVIDER PROCEDURE MANUAL
1 OF 10 DOCUMENT HISTORY LOG STATUS REVISION EFFECTIVE DESCRIPTION Revision 1.1 Sep. 1, 2015 Baseline 1.0 Feb. 1, 2015 3.1 Eligible Entity 5 CAD Claim Submission o Instruction update and email address.
More informationPrinted copies are for reference only. Please refer to the electronic copy of this policy for the latest version.
340B Pharmacy Audit Policy Version: 1.4 Date Created: 01/05/2015 Date Approved: 02/18/2015 Printed copies are for reference only. Please refer to the electronic copy of this policy for the latest version.
More information340B University Page 1 340B Manager and Coordinator Job Description Template
340B University Page 1 Purpose: The purpose of this tool is to provide a list of activities commonly assigned to the role of 340B Manager or Coordinator. This list is not exhaustive, rather a compilation
More informationMaximizing the 340B Drug Discount Program: A Webinar for Finance Executives in 340B Hospitals Webinar
Maximizing the 340B Drug Discount Program: A Webinar for Finance Executives in 340B Hospitals Webinar January 20, 2010 The Webinar Will Begin Momentarily National Association of Public Hospitals and Health
More information340B Program New Developments and Increasing Scrutiny
340B Program New Developments and Increasing Scrutiny Todd Nova Hall Render tnova@hallrender.com Wisconsin Office of Rural Health Hospital Finance Workshop August 24, 2012 What We Will Cover 2 340B Program
More informationStructuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements
Presenting a live 90-minute webinar with interactive Q&A Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements THURSDAY, JUNE 4, 2015 1pm Eastern 12pm Central 11am
More information340B Compliance Self-Assessment: Self-Audit Process Page 1 A Sample Self-Audit Process for Community Health Centers
340B Compliance Self-Assessment: Self-Audit Process Page 1 Purpose: The purpose of this tool is to provide a sample internal audit process to assist participating community health center (CHC) leaders
More informationImplementing a System-wide 340B Program
Implementing a System-wide 340B Program An Overview Steve Pitzer System Executive, Supply Chain Management CHRISTUS Health Sam Colletti, RPh Director of Enterprise Accounts- CHRISTUS Health Broadlane Objectives
More information340B DRUG DISCOUNT PROGRAM OMNIBUS GUIDANCE. Presented by the American Bar Association Health Law Section and Center for Professional Development
340B DRUG DISCOUNT PROGRAM OMNIBUS GUIDANCE Presented by the American Bar Association Health Law Section and Center for Professional Development American Bar Association Center for Professional Development
More informationA fter much-anticipation, the Health Resources and
BNA s Health Care Policy Report Reproduced with permission from BNA s Health Care Policy Report, 23 HCPR 1420, 09/21/2015. Copyright 2015 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com
More information340B Drug Pricing Program: Recent Developments and Compliance Update
340B Drug Pricing Program: Recent Developments and Compliance Update Elizabeth S. Elson, Esq. Anil Shankar, Esq. November 19, 2015 Attorney Advertising Prior results do not guarantee a similar outcome
More informationAlabama Department of Public Health Drug Purchasing Programs: 340B and MMCAP. Alabama Department of Public Health 8/20/2012
Alabama Department of Public Health Drug Purchasing Programs: 340B and MMCAP Satellite Conference and Live Webcast Thursday, August 23, 2012 2:00 4:00 p.m. Central Time Produced by the Alabama Department
More informationPHARMACY CARE ----- FQHCs AND 340B PROGRAM
PHARMACY CARE ----- FQHCs AND 340B PROGRAM HISTORY OF 340B PROGRAM Initiated during Clinton administration Who can participate? FQHC, Family Planning, Ryan White, Black Lung, Hemophilia, Urban Indian,
More information7/16/2010. 14 th Annual 340B Coalition Conference July 19, 2010 Washington, DC. Safety Net Hospitals for Pharmaceutical Access
Safety Net Hospitals for Pharmaceutical Access The Story From Washington, D.C. Ted Slafsky Executive Director, SNHPA Editor in Chief, Drug Discount Monitor (202)552-58605860 ted.slafsky@snhpa.org 14 th
More informationThe 340B Drug Pricing Program. Ariel Winter and Daniel Zabinski November 6, 2014
The 340B Drug Pricing Program Ariel Winter and Daniel Zabinski November 6, 2014 Outline Background on 340B program Program has grown substantially 340B statute does not define key terms, allows many providers
More informationSUMMARY OF HRSA PROPOSED OMNIBUS GUIDANCE ON THE 340B DRUG DISCOUNT PROGRAM
L A W O F F I C E S HYMAN, PHELPS & MCNAMARA, P.C. 7 0 0 T H I R T E E N T H S T R E E T, N. W. S U I T E 1 2 0 0 W A S H I N G T O N, D. C. 2 0 0 0 5-5 9 2 9 ( 2 0 2 ) 7 3 7-5 6 0 0 F A C S I M I L E
More information340B Mega Guidance: Implications for Essential Hospitals Sarah Mutinsky and Barbara Eyman Washington Counsel, America s Essential Hospitals Eyman
340B Mega Guidance: Implications for Essential Hospitals Sarah Mutinsky and Barbara Eyman Washington Counsel, America s Essential Hospitals Eyman Associates September 10, 2015 TODAY S AGENDA Background
More informationSUMMARY: The Health Resources and Services Administration (HRSA) administers section
This document is scheduled to be published in the Federal Register on 08/28/2015 and available online at http://federalregister.gov/a/2015-21246, and on FDsys.gov Billing Code: 4165-15 DEPARTMENT OF HEALTH
More informationOctober 27, 2015. Attention: RIN 0906-AB08. RE: 340B Drug Pricing Program Omnibus Guidance. Dear Captain Pedley:
Captain Krista Pedley, Director Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane Mail Stop 08W05A Rockville, MD 20857 Attention: RIN 0906-AB08 RE: 340B Drug Pricing
More informationThe Federal 340B Drug Discount Program: A Primer
The Federal 340B Drug Discount Program: A Primer Andrea G. Cohen Manatt, Phelps & Phillips, LLP Presentation to the National Medicaid Congress June 4, 2006 Preview 340B Program Overview What is it Who
More informationThe PHS 340B Drug Pricing Program
340B DRUG PRICING PROGRAM: Improving access to affordable medications. Harry P. Hagel, RPh, MS Senior Director HRSA Pharmacy Services Support Center American Pharmacists Association August 16, 2006 The
More information340B and the Pharmacy Wholesaler s Role
340B and the Pharmacy Wholesaler s Role Daniel Neal Sr. Product/Market Mgr., 340B Innovative Delivery Solutions 10 th Annual 340B Coalition Winter Conference Wednesday, February 5, 2014 Disclaimer The
More informationOPA DATABASE GUIDE PUBLIC USERS - RECERTIFICATION FOR AUGUST 2013 VERSION 5.2.1
OPA DATABASE GUIDE FOR PUBLIC USERS - RECERTIFICATION AUGUST 2013 VERSION 5.2.1 CERTIFICATION 1 Authorizing Official (AO) Advance Notification 1 340B Recertification Email 2 AO Logging In 3 Navigating
More information(RIN) 0906-AB08; 340-B
October, 2015 Ms. Krista Pedley Director, Office of Pharmacy Affairs (OPA) Health Resources and Services Administration (HRSA) 5600 Fishers Lane, Mail Stop 08W05A Rockville, Maryland 20857 Re: Regulatory
More informationan analysis of 340B solutions a white paper by Michael J. Sovie, Pharm.D., MBA
an analysis of 340B solutions a white paper by Michael J. Sovie, Pharm.D., MBA Disclaimer Please be advised that the following information is provided for reference purposes only. This information does
More informationStatement of the Biotechnology Industry Organization Before the Advisory Panel on Ambulatory Payment Classification Groups August 23-24, 2010
Statement of the Biotechnology Industry Organization Before the Advisory Panel on Ambulatory Payment Classification Groups August 23-24, 2010 Laurel Todd Director, Reimbursement and Health Policy Biotechnology
More informationIs your organization 340B equipped? Understanding Contract Pharmacy arrangements
Is your organization 340B equipped? Understanding Contract Pharmacy arrangements In today s era of healthcare reform that emphasizes enhanced accessibility and cost reductions, the 340B program remains
More informationHHS Releases Long-Awaited 340B Proposed Guidance
AUGUST 31, 2015 HHS Releases Long-Awaited 340B Proposed Guidance David Ivill, Emily Cook and Joseph Parise On August 27, 2015, the U.S. Department of Health and Human Services (HHS) released the long-awaited
More informationMedicaid and 340B. Presentation to: GHA 340B Day Presented by: Linda Wiant, Pharm.D. Pharmacy Director. Date: 10-23-14 0
Medicaid and 340B Presentation to: GHA 340B Day Presented by: Linda Wiant, Pharm.D. Pharmacy Director Date: 10-23-14 0 Mission The Georgia Department of Community Health We will provide Georgians with
More informationSTATEMENT OF DIANA ESPINOSA DEPUTY ADMINISTRATOR, HEALTH RESOURCES AND SERVICES ADMINISTRATION BEFORE THE
STATEMENT OF DIANA ESPINOSA DEPUTY ADMINISTRATOR, HEALTH RESOURCES AND SERVICES ADMINISTRATION BEFORE THE U.S. HOUSE ENERGY AND COMMERCE COMMITTEE SUBCOMMITEE ON HEALTH WASHINGTON, D.C. MARCH 5, 2015 Good
More informationNAMD WORKING PAPER SERIES. Medicaid and the 340B Program: Alignment and Modernization Opportunities
NAMD WORKING PAPER SERIES Medicaid and the 340B Program: Alignment and Modernization Opportunities May 2015 444 North Capitol Street, Suite 524 Washington, DC 20001 Phone: 202.403.8620 www.medicaiddirectors.org
More informationSafety Net Hospitals for Pharmaceutical Access
Safety Net Hospitals for Pharmaceutical Access December 24, 2008 Ms. Alberta J. Dwivedi Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-1404-FC Mail Stop
More informationPART B PAYMENTS FOR 340B-PURCHASED DRUGS
Department of Health and Human Services OFFICE OF INSPECTOR GENERAL PART B PAYMENTS FOR 340B-PURCHASED DRUGS Suzanne Murrin Deputy Inspector General for Evaluation and Inspections November 2015 OEI-12-14-00030
More informationThe 340B Program: Today and Beyond
FL Regional Education Session - Tampa The 340B Program: Today and Beyond May 19, 2015 2:15-3:15 PM ET 2015 Safety Net Hospitals for Pharmaceutical Access 1 Disclaimer This presentation is not to be construed
More information340B Drug Pricing Program Results of a Survey of Eligible but Non-Participating Rural Hospitals
340B Drug Pricing Program Results of a Survey of Eligible but Non-Participating Rural Hospitals A Joint Publication of The North Carolina Rural Health Research & Policy Analysis Center (1) Working Paper
More informationTHE 340B DRUG DISCOUNT PROGRAM A Review and Analysis of the 340B Program
THE 340B DRUG DISCOUNT PROGRAM A Review and Analysis of the 340B Program WINTER 2013 A publication of the following organizations: the Biotechnology Industry Organization (BIO), the Community Oncology
More informationOverview of Drug Pricing for Public Programs
Overview of Drug Pricing for Public Programs 1 J U L I E C R O S S, I N D E P E N D E N T C O N S U L T A N T A N N E D O N N E L L Y, P R O J E C T I N F O R M A N D F A I R P R I C I N G C O A L I T
More information340B Policy Landscape
340B Policy Landscape Providence 2015 340B Summit Presented by Steve Brennan, Director, Public Policy Providence Health & Services Sept. 28, 2015 1 Today s topics Backdrop of debate over 340B program Legislative
More informationHot Topics in Medicaid
Hot Topics in Medicaid Chad Hope, Pharm.D. Pharmacy Program Manager DHSS/DHCS chad.hope@alaska.gov; 907-334-2654 ***These slides had to be submitted in December 2014 and may contain outdated information***
More informationDate: September 3, 2014
Date: September 3, 2014 Subject: Background on Sections 401 and 403 of the Indian Health Care Improvement Act: Disregarding Certain Payments in Determining Appropriations and Reporting Requirements Note:
More informationTHE 340B DRUG DISCOUNT PROGRAM A Review and Analysis of the 340B Program
THE 340B DRUG DISCOUNT PROGRAM A Review and Analysis of the 340B Program WINTER 2013 A publication of the following organizations: the Biotechnology Industry Organization (BIO), the Community Oncology
More information42 USC 256b. NB: This unofficial compilation of the U.S. Code is current as of Jan. 4, 2012 (see http://www.law.cornell.edu/uscode/uscprint.html).
TITLE 42 - THE PUBLIC HEALTH AND WELFARE CHAPTER 6A - PUBLIC HEALTH SERVICE SUBCHAPTER II - GENERAL POWERS AND DUTIES Part D - Primary Health Care subpart vii - drug pricing agreements 256b. Limitation
More informationO n Aug. 28, the Department of Health and Human
BNA s Health Law Reporter Reproduced with permission from BNA s Health Law Reporter, 24 HLR 1202, 9/17/15. Copyright 2015 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com HRSA
More informationGROWTH OF THE 340B PROGRAM: PAST TRENDS, FUTURE PROJECTIONS
: PAST TRENDS, FUTURE PROJECTIONS Healthcare WHITE PAPER NOVEMBER 2014 Prepared By: Aaron Vandervelde avandervelde@thinkbrg.com 202.480.2661 Copyright 2014 by Berkeley Research Group, LLC. Except as may
More informationREQUEST FOR PROPOSALS
REQUEST FOR PROPOSALS First Choice Community Healthcare, Inc. (FCCH), is seeking competitive proposals for the provision of 340B pharmacy benefit management services Small, women owned, and minority owned
More informationHemophilia Treatment Center Manual for Participating in the Drug Pricing Program Established by Section 340B of the Public Health Service Act
Hemophilia Treatment Center Manual for Participating in the Drug Pricing Program Established by Section 340B of the Public Health Service Act July 2005 Table of Contents Introduction 4 Part I: Major Elements
More informationSession 1: Core Pharmaceutical Datasets Retail and Non Retail Laura Jenkins Jirele
Session 1: Core Pharmaceutical Datasets Retail and Non Retail Laura Jenkins Jirele PMSA Virtual University PMSA Virtual University is conducting this 4 part webinar series focused on the introduction and
More informationHRSA Issues Proposed Omnibus 340B Guidance
HRSA Issues Proposed Omnibus 340B Guidance September 2015 1 HRSA Issues Proposed Omnibus 340B Guidance John Gould, Jeffrey L. Handwerker, Rosemary Maxwell, Matthew T. Fornataro, Kristin M. Hicks, Rahul
More informationAnthem s Prescription Drug Plan
This information applies only to clients migrating from legacy WellPoint NextRx to Express Scripts, and does not apply to new clients implementing the Anthem prescription drug plan in 2010. Anthem s Prescription
More informationExpanding 340B Participation: The Provider-Based Challenge
Expanding 340B Participation: The Provider-Based Challenge Presentation by Karen Smith, Esq. & David Johnston, Esq. Bricker & Eckler LLP www.bricker.com Columbus l Cleveland l Cincinnati-Dayton I Marietta
More informationPart B drug payment policy issues
Part B drug payment policy issues C h a p t e r3 C H A P T E R 3 Part B drug payment policy issues Chapter summary In this chapter Medicare Part B covers drugs that are administered by infusion or injection
More informationEmpire s Prescription Drug Plan
Empire s Prescription Drug Plan Empire s prescription drug program is about more than processing claims and making prescriptions available. It s about looking at each person as an individual. Because we
More informationDSH Litigation and 340B Program Update: What Participating Hospitals Need to Know and What They Should Be Doing
DSH Litigation and 340B Program Update: What Participating Hospitals Need to Know and What They Should Be Doing Presented by: Joe Metro, Partner Sal Rotella, Partner Agenda Disproportionate Share Hospital
More informationSTATES COLLECTION OF REBATES FOR DRUGS PAID THROUGH MEDICAID MANAGED CARE ORGANIZATIONS
Department of Health and Human Services OFFICE OF INSPECTOR GENERAL STATES COLLECTION OF REBATES FOR DRUGS PAID THROUGH MEDICAID MANAGED CARE ORGANIZATIONS Daniel R. Levinson Inspector General September
More informationChallenges and Opportunities
The Future of the 340B Drug Pricing Program: Challenges and Opportunities Jeffrey R. Lewis jeffreyrobertlewis@gmail.com Mr. Lewis is the former President of PS2 Health Care and now serves as the Chief
More information